Evergreen Capital Management’s Dr. Reddy's Laboratories RDY Stock Holding History

Evergreen Capital Management’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$199K	Sell	13,728 -13,590	-50%	-$183K	﹤0.01%	1470
2026 Q1	$378K	Sell	27,318 -6,675	-20%	-$92.9K	0.01%	965
2025 Q4	$477K	Buy	33,993 +2,249	+7%	+$31.5K	0.01%	772
2025 Q3	$444K	Buy	31,744 +2,393	+8%	+$34.4K	0.01%	721
2025 Q2	$441K	Buy	+29,351	New	+$419K	0.01%	617
2025 Q1	–	Sell	-10,713	Closed	-$169K	–	1165
2024 Q4	$169K	Buy	+10,713	New	+$161K	0.01%	1018

Other funds holding RDY

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

AIM

Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Evergreen Capital Management's RDY Position: Q2 2026 in Review

Evergreen Capital Management reduced its Dr. Reddy's Laboratories (RDY) stake by 50% in Q2 2026, selling an estimated $183K and leaving 13,728 shares worth $199K. The position accounts for ﹤0.01% of the portfolio, ranked #1470.

Evergreen Capital Management first reported a position in RDY in Q4 2024 and has held it in 6 quarters since. The position peaked at $477K in Q4 2025. 239 funds tracked by Wall St. Rank hold RDY as of Q2 2026.

Evergreen Capital Management held 13,728 shares of Dr. Reddy's Laboratories worth $199K as of Q2 2026.
Evergreen Capital Management sold 13,590 Dr. Reddy's Laboratories shares in Q2 2026, an estimated $183K.
Dr. Reddy's Laboratories made up ﹤0.01% of Evergreen Capital Management's portfolio in Q2 2026, its #1470 holding.
Evergreen Capital Management first reported a position in Dr. Reddy's Laboratories in Q4 2024 and has held it in 6 quarters since.
Evergreen Capital Management's Dr. Reddy's Laboratories position peaked at $477K in Q4 2025.
239 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2026.

Based on Evergreen Capital Management's 13F filing for Q2 2026, filed 23 Jul 2026.